Good points, Early. (Kiril, what were your concerns with the accounts? The only problem I see is the negative cashflow, despite the good profit.)
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025